A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs

The CD95 (also called APO-1 or Fas) system plays a major role in the induction of apoptosis in lymphoid and nonlymphoid tissues in response to a variety of extracellular signals, including chemotherapeutic drugs. Here we report that the CD95 ligand (CD95L) is upregulated in hepatoma cells upon treat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Eichhorst, Sören (VerfasserIn) , Li-Weber, Min (VerfasserIn) , Schulze-Bergkamen, Henning (VerfasserIn) , Angel, Peter (VerfasserIn) , Krammer, Peter H. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: Oct. 2000
In: Molecular and cellular biology
Year: 2000, Jahrgang: 20, Heft: 20, Pages: 7826-7837
ISSN:1098-5549
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC86378/
Volltext
Verfasserangaben:Sören T. Eichhorst, Martina Müller, Min Li-Weber, Henning Schulze-Bergkamen, Peter Angel, and Peter H. Krammer

MARC

LEADER 00000caa a2200000 c 4500
001 1755914237
003 DE-627
005 20230428043056.0
007 cr uuu---uuuuu
008 210426s2000 xx |||||o 00| ||eng c
035 |a (DE-627)1755914237 
035 |a (DE-599)KXP1755914237 
035 |a (OCoLC)1341405891 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Eichhorst, Sören  |d 1971-  |e VerfasserIn  |0 (DE-588)123616034  |0 (DE-627)08266269X  |0 (DE-576)29379197X  |4 aut 
245 1 2 |a A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs  |c Sören T. Eichhorst, Martina Müller, Min Li-Weber, Henning Schulze-Bergkamen, Peter Angel, and Peter H. Krammer 
264 1 |c Oct. 2000 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 26.04.2021 
520 |a The CD95 (also called APO-1 or Fas) system plays a major role in the induction of apoptosis in lymphoid and nonlymphoid tissues in response to a variety of extracellular signals, including chemotherapeutic drugs. Here we report that the CD95 ligand (CD95L) is upregulated in hepatoma cells upon treatment with antineoplastic drugs. Upregulation by different chemotherapeutic drugs is functionally relevant for drug-induced apoptosis and is mediated by transcriptional mechanisms. The MEKK1/JNKK pathway and a novel AP-1 element in the CD95L promoter downstream of the TATA box are required for CD95L upregulation. Thus, understanding the mechanisms of CD95-mediated apoptosis through CD95L upregulation upon treatment of hepatocellular carcinomas with chemotherapeutic drugs may contribute to the improvement of anticancer chemotherapy. 
700 1 |a Li-Weber, Min  |e VerfasserIn  |0 (DE-588)1157205399  |0 (DE-627)1021010324  |0 (DE-576)502732695  |4 aut 
700 1 |a Schulze-Bergkamen, Henning  |d 1971-  |e VerfasserIn  |0 (DE-588)120914387  |0 (DE-627)080966403  |0 (DE-576)292444907  |4 aut 
700 1 |a Angel, Peter  |e VerfasserIn  |0 (DE-588)1080056572  |0 (DE-627)843623179  |0 (DE-576)453297668  |4 aut 
700 1 |a Krammer, Peter H.  |d 1946-  |e VerfasserIn  |0 (DE-588)121766373  |0 (DE-627)081520255  |0 (DE-576)292873417  |4 aut 
773 0 8 |i Enthalten in  |t Molecular and cellular biology  |d London : Taylor & Francis, 1981  |g 20(2000), 20, Seite 7826-7837  |h Online-Ressource  |w (DE-627)269533656  |w (DE-600)1474919-1  |w (DE-576)088704181  |x 1098-5549  |7 nnas  |a A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs 
773 1 8 |g volume:20  |g year:2000  |g number:20  |g pages:7826-7837  |g extent:12  |a A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs 
856 4 0 |u https://www.ncbi.nlm.nih.gov/pmc/articles/PMC86378/  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210426 
993 |a Article 
994 |a 2000 
998 |g 121766373  |a Krammer, Peter H.  |m 121766373:Krammer, Peter H.  |d 50000  |e 50000PK121766373  |k 0/50000/  |p 6  |y j 
998 |g 1080056572  |a Angel, Peter  |m 1080056572:Angel, Peter  |d 50000  |e 50000PA1080056572  |k 0/50000/  |p 5 
998 |g 120914387  |a Schulze-Bergkamen, Henning  |m 120914387:Schulze-Bergkamen, Henning  |d 50000  |e 50000PS120914387  |k 0/50000/  |p 4 
998 |g 1157205399  |a Li-Weber, Min  |m 1157205399:Li-Weber, Min  |d 50000  |e 50000PL1157205399  |k 0/50000/  |p 3 
999 |a KXP-PPN1755914237  |e 3917684071 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"origin":[{"dateIssuedDisp":"Oct. 2000","dateIssuedKey":"2000"}],"title":[{"title":"A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs","title_sort":"novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs"}],"recId":"1755914237","type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"family":"Eichhorst","given":"Sören","display":"Eichhorst, Sören","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Li-Weber, Min","family":"Li-Weber","given":"Min"},{"given":"Henning","family":"Schulze-Bergkamen","display":"Schulze-Bergkamen, Henning","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Angel","given":"Peter","display":"Angel, Peter","roleDisplay":"VerfasserIn","role":"aut"},{"roleDisplay":"VerfasserIn","role":"aut","given":"Peter H.","family":"Krammer","display":"Krammer, Peter H."}],"relHost":[{"note":["Gesehen am 14.07.2023"],"titleAlt":[{"title":"MCB"}],"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["1.1981 -"],"corporate":[{"display":"American Society for Microbiology","role":"isb","roleDisplay":"Herausgebendes Organ"}],"id":{"zdb":["1474919-1"],"issn":["1098-5549"],"eki":["269533656"]},"disp":"A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugsMolecular and cellular biology","part":{"text":"20(2000), 20, Seite 7826-7837","extent":"12","issue":"20","volume":"20","pages":"7826-7837","year":"2000"},"title":[{"title":"Molecular and cellular biology","subtitle":"MCB","title_sort":"Molecular and cellular biology"}],"language":["eng"],"origin":[{"dateIssuedDisp":"1981-","publisher":"Taylor & Francis ; Soc.","dateIssuedKey":"1981","publisherPlace":"London ; Washington"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"name":{"displayForm":["American Society for Microbiology"]},"recId":"269533656"}],"name":{"displayForm":["Sören T. Eichhorst, Martina Müller, Min Li-Weber, Henning Schulze-Bergkamen, Peter Angel, and Peter H. Krammer"]},"physDesc":[{"extent":"12 S."}],"note":["Gesehen am 26.04.2021"],"id":{"eki":["1755914237"]}} 
SRT |a EICHHORSTSNOVELAP1EL2000